Dear Colleagues,

 

The population of older adults is increasing throughout the world and with it, the prevalence of cardiovascular disease (CVD). This has created distinctive, age-related management challenges. The population in the United States (US) >/= 65 years old has increased from 3 million in 1900 to about 46 million currently, and is expected to reach almost 84 million by 2050. The population aged ≥85 years was only about 0.2% of the total US population in 1900, but is anticipated to reach 5–6% by 2050. This extended lifespan increases the exposure to the cumulative effects of CVD risk factors, as well as to age-related physiological changes that increase the susceptibility to CVD incidence and progression. The prevalence of almost every type of CVD increases with age, including many that tend to develop predominantly in older adults (e.g., aortic stenosis, heart failure, atrial fibrillation). Furthermore, CVD in older adults is often more complex than in younger populations, both in terms of its pathophysiology and its superimposition upon multiple comorbidities. Adults aged ≥75 years currently comprise only about 6% of the US population, but account for >50% of all CVD deaths. 
To address the complexities of CVD in older adults, RCM is dedicating an entire issue to Heart Health and Aging. Manuscripts may focus on the epidemiology, pathophysiology, diagnosis, management, or prognosis of CVD in older adults, as well as on CVD preventive strategies in this age group. 

Dr. Jerome L. Fleg

Guest Editor